Get a glimpse into our company and investor data—powered by the PitchBook Platform
Later Stage VCLATEST DEAL TYPE
$4.41MLATEST DEAL AMOUNT
Operator of a biotechnology firm intended to develop and commercialize innovative portable high-speed PCR devices. The company's biotechnology products create new life science tools in order to lead the next-generation molecular diagnostic market.